📰 Polypid Daily News
Page 2 - Polypid Daily News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Polypid Daily. Real-time updates on events, politics, business and more.
September 15, 2023
PolyPid Ltd. (NASDAQ:PYPD – Get Free Report) was the target of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 13,300 shares, a decrease of 81.3% from the August 15th total of 71,100 shares. Based on an average daily trading volume, of 66,000 shares, […]
August 27, 2023
PolyPid (NASDAQ:PYPD – Get Free Report) and Merit Medical Systems (NASDAQ:MMSI – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Profitability This table compares PolyPid and Merit Medical […]
August 8, 2023
PolyPid (NASDAQ:PYPD – Get Free Report) is set to issue its quarterly earnings data before the market opens on Wednesday, August 9th. Parties that wish to listen to the company’s conference call can do so using this link. PolyPid (NASDAQ:PYPD – Get Free Report) last posted its quarterly earnings results on Wednesday, May 10th. The […]
July 5, 2023
PolyPid Ltd. (NASDAQ:PYPD – Free Report) was the recipient of a significant drop in short interest during the month of June. As of June 15th, there was short interest totalling 88,000 shares, a drop of 29.1% from the May 31st total of 124,100 shares. Based on an average daily volume of 112,600 shares, the days-to-cover […]
July 4, 2023
PolyPid Ltd. (NASDAQ:PYPD – Free Report) was the target of a large drop in short interest in June. As of June 15th, there was short interest totalling 88,000 shares, a drop of 29.1% from the May 31st total of 124,100 shares. Based on an average daily volume of 112,600 shares, the days-to-cover ratio is currently […]
June 26, 2023
PolyPid (NASDAQ:PYPD – Get Rating) and Ra Medical Systems (NYSE:RMED – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, analyst recommendations and profitability. Insider and Institutional Ownership 2.5% of PolyPid shares are […]
May 26, 2023
PolyPid Ltd. (NASDAQ:PYPD – Get Rating) shares traded up 4.8% during trading on Wednesday . The stock traded as high as $0.39 and last traded at $0.37. 94,833 shares were traded during trading, a decline of 67% from the average session volume of 288,958 shares. The stock had previously closed at $0.35. PolyPid Price Performance […]
May 26, 2023
PolyPid Ltd. (NASDAQ:PYPD – Get Rating) was up 4.8% during trading on Wednesday . The company traded as high as $0.39 and last traded at $0.37. Approximately 94,833 shares traded hands during mid-day trading, a decline of 67% from the average daily volume of 288,958 shares. The stock had previously closed at $0.35. PolyPid Stock […]
May 5, 2023
PolyPid Ltd. (NASDAQ:PYPD – Get Rating) was down 1.2% during trading on Tuesday . The company traded as low as $0.40 and last traded at $0.41. Approximately 17,516 shares changed hands during trading, a decline of 95% from the average daily volume of 325,541 shares. The stock had previously closed at $0.41. PolyPid Stock Down […]
February 2, 2023
Raymond James Financial Services Advisors Inc. trimmed its position in shares of PolyPid Ltd. (NASDAQ:PYPD – Get Rating) by 36.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,814 shares of the company’s stock after selling 19,447 shares during the […]